Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nassim Zamani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Artificial Cells, Nanomedicine, and Biotechnology|September 28, 2018
Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analysesArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Therapeutic Delivery|November 17, 2018
Eudragit<sup>®</sup>-based microcapsules of probucol with a gut-bacterial processed secondary bile acidArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Therapeutic Delivery|February 8, 2019
Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatmentArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|February 12, 2020
A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compoundsArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Nanotechnology, Science and Applications|February 6, 2020
Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-CellsArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Current Diabetes Reviews|February 5, 2020
Modulatory Nano/Micro Effects of Diabetes Development on Pharmacology of Primary and Secondary Bile Acids ConcentrationsArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Plos One|April 5, 2019
An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniquesArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|November 14, 2018
Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetesArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Therapeutic Delivery|October 25, 2019
Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic miceArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Pharmacological Reports : PR|February 13, 2020
Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammationArmin Mooranian, Nassim Zamani, Corina M Ionescu, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Artificial Cells, Nanomedicine, and Biotechnology|September 28, 2018
Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analysesArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Therapeutic Delivery|November 17, 2018
Eudragit<sup>®</sup>-based microcapsules of probucol with a gut-bacterial processed secondary bile acidArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Therapeutic Delivery|February 8, 2019
Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatmentArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|February 12, 2020
A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compoundsArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Nanotechnology, Science and Applications|February 6, 2020
Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-CellsArmin Mooranian, Nassim Zamani, Momir Mikov, et al.
Current Diabetes Reviews|February 5, 2020
Modulatory Nano/Micro Effects of Diabetes Development on Pharmacology of Primary and Secondary Bile Acids ConcentrationsArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Plos One|April 5, 2019
An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniquesArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Artificial Cells, Nanomedicine, and Biotechnology|November 14, 2018
Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetesArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Therapeutic Delivery|October 25, 2019
Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic miceArmin Mooranian, Nassim Zamani, Ryu Takechi, et al.
Pharmacological Reports : PR|February 13, 2020
Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammationArmin Mooranian, Nassim Zamani, Corina M Ionescu, et al.
Pageof 2